Evidence map›Paper›PMID 35502028›Full record

ArticleIndian journal of ophthalmology2022

Photo-activated chromophore for infectious keratitis cross-linking and its efficacy as a treatment modality in managing microbial keratitis.

Sanchita Saini, Satyaprakash Singh, Kshama Dwivedi, Sanskriti Singh, Santosh Kumar, Jagriti Rana

Open access · diamondAbstract read
In one paragraph

Article in Indian journal of ophthalmology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Sanchita SainiDepartment of Ophthalmology, King George Medical College, Lucknow, Uttar Pradesh, India.
Satyaprakash SinghDepartment of Ophthalmology, Regional Institute of Ophthalmology, Government M. D. Eye Hospital, Prayagraj (Allahabad), Uttar Pradesh, India.
Kshama DwivediDepartment of Ophthalmology, Regional Institute of Ophthalmology, Government M. D. Eye Hospital, Prayagraj (Allahabad), Uttar Pradesh, India.
Sanskriti SinghDepartment of Ophthalmology, Regional Institute of Ophthalmology, Government M. D. Eye Hospital, Prayagraj (Allahabad), Uttar Pradesh, India.
Santosh KumarDepartment of Ophthalmology, Regional Institute of Ophthalmology, Government M. D. Eye Hospital, Prayagraj (Allahabad), Uttar Pradesh, India.
Jagriti RanaDepartment of Ophthalmology, Regional Institute of Ophthalmology, Government M. D. Eye Hospital, Prayagraj (Allahabad), Uttar Pradesh, India.
King George's Medical University · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: To assess Photo Activated Chromophore for Infective Keratitis-Cross Linking (PACK-CXL) and its efficacy as a treatment modality in managing microbial keratitis. Methods: Single Centre prospective interventional study in infectious keratitis. A total of eleven patients were taken who had corneal thickness (CT) more than 400μm. PACK-CXL was performed according to Dresden's protocol. The response was assessed by slit lamp examination, BCVA and AS-OCT at the time of complete healing. Results: The mean visual acuity at presentation was 1.207logMAR (0.3-3) which improved to mean value of 0.53logMAR (0.3-1). Mean time taken for complete epithelization was 17.45 days (14- 30 days) and that for complete healing was 33.72 days (21- 60 days). Mean CT at the baseline was 650.5± 108μm which reduced on consecutive follow up visits. There was reduction in the symptoms in nine patients except in two. One case reported increase in symptoms with worsening increase in endoexudates and hypopyon, and the other developed drug toxicity due to topical medications. Conclusion: Patients who underwent PACK-CXL showed good and early healing, good remodelling of cornea and improved visual acuity. The recalcitrant cases became responders to the same medications after PACK-CXL. Thus, PACK-CXL works well for both fungal and bacterial keratitis.

Indexed as

KeratitisPhotochemotherapyCross-Linking ReagentsHumansPhotosensitizing AgentsProspective StudiesRiboflavinUltraviolet RaysCross-Linking ReagentsPhotosensitizing AgentsRiboflavinCollagen crosslinkingcorneal ulcerfungal keratitiskeratitisPACK-CXL

Identifiers

PMID35502028
PMCPMC9333004
OpenAlexW4225410878

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.